Keywords: CEST / APT / NOE, CEST & MT, HIV
Motivation: While anti-retroviral therapy (ART) is essential for combating the type-one human immunodeficiency virus (HIV-1), patients with undetectable viral load still experience HIV-associated neurocognitive disorders.
Goal(s): We aimed to use the chemical exchange saturation transfer (CEST) effects of brain metabolites with MRI to elucidate HIV-associated neurocognitive outcomes on ART patients.
Approach: Humanized mice were infected with HIV-1, then given daily treatment of ART or vehicle. CEST-MRI and MRS were used to evaluate brain metabolites at four key timepoints.
Results: Untreated mice showed declining 2ppm and 3ppm CEST signal in key brain regions, alongside increasing NOE signal. This was partially validated with MRS.
Impact: The metabolic insights that CEST-MRI offers to HIV immunological care may aid in the development of increasingly effective ART drugs, such as long-acting injectables. Increased efficacy of ART will allow for increased quality of life for people living with HIV.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords